Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Homeopathy among 18 items NHS could scrap from prescriptions

NHS England has launched a public consultation on whether 18 products and treatments – including homeopathy and herbal medicines – should be scrapped from prescriptions.

The commissioner estimates the 18 “ineffective, over-priced and low-value” treatments cost taxpayers £141 million a year and “should generally not be prescribed”, it said in a statement last Friday (July 21).

In its consultation – which will run until October 21 – NHS England also asks for views on 3,200 prescription items – such as headlice treatments and nasal sprays – which are “readily available” over the counter, and which it estimates currently cost taxpayers £645m a year.

The consultation will result in prescribing guidance for clinical commissioning groups (CCGs), it said.

NHS England is “also supportive of restricting availability of gluten-free foods on prescription, which costs £26m a year, and is currently subject to a Department of Health consultation”.

Graham Jackson, GP and co-chair chair of NHS Clinical Commissioners (NHSCC) – the independent organisation representing CCGs which has partnered with NHS England – said the consultation is “an important part” of looking at what the NHS should provide.

“We are pleased to have worked with NHS England to identify products that could be considered low priority for NHS funding, for reasons including limited clinical effectiveness or the availability of cost-effective alternatives,” Dr Jackson said.

“Serious concerns”

The Royal Pharmaceutical Society (RPS) said while “ineffective and unsafe medicines should not be prescribed on the NHS”, it has “serious concerns” about the proposed restrictions on prescribing clinically effective medicines to treat common conditions, such as headlice or athlete’s foot.

RPS England board chair Sandra Gidley said expecting everyone to pay for medicines for common conditions would “further increase inequalities”, because “those on low incomes will be disproportionately affected”.

“They should not be denied treatment because of an inability to pay,” Ms Gidley said.

“People with minor health problems should be treated via NHS pharmacy minor ailment schemes,” she added.

Scrapping homeopathy welcomed

However, the RPS did welcome the inclusion of homeopathy in the list of 18 products.

“Removing homeopathy, which has no scientific or pharmacological basis, from NHS supply is long overdue,” it said.

NHS England's chief executive Simon Stevens described homeopathy as "at best a placebo and a misuse of scarce NHS funds".

Last month, C+D hosted a roundtable debate with NHSCC co-chair Graham Jackson and Ms Gidley, among others, to discuss plans to scrap certain products from prescriptions. The results of the debate will be published on the C+D website in August.

What are the 18 products NHS England wants to scrap from prescriptions?

  • Co-proxamol
  • Omega 3 fatty acid compounds
  • Lidocaine plasters 
  • Rubefacients 
  • Dosulepin 
  • Glucosamine and chondroiton
  • Lutein and antioxidants
  • Oxycodone and naloxone
  • Homeopathy items
  • Herbal medicines
  • Liothyronine
  • Doxazosin modified release (MR)
  • Perindopril arginine
  • Fentanyl immediate-release
  • Tadalafil once-daily
  • Trimipramine
  • Paracetamol and tramadol combination product
  • Travel vaccines – seven vaccines, which are not available on the NHS, but are sometimes prescribed in error: hepatitis B; Japanese encephalitis; meningitis ACWY; yellow fever; tick-borne encephalitis; rabies; and the Bacillus Calmette-Guérin (BCG) vaccine.

Read the full consultation, and the reasons why these 18 products are being considered, here.

Source: NHS England

Do you agree with NHS England's plans?

Related Content

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD008857

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel